Skip to content
TopDivs

BBC Dividend

Virtus Biotech Clinical Trials ETF

AMEXFinancial ServicesETFData as of
Dividend yield
1.25%
Annual dividend
$0.66
Payout ratio
Frequency
Annual
Share price
$52.30
Market cap
$49.7M

Is BBC a good dividend stock?

What the data shows. These are observations, not recommendations — see the disclaimer at the foot of the page.

  • Yield is below the market median1.25% against a median of 2.78%. A lower yield is common among companies that reinvest more of their earnings or whose shares have risen.
  • Payout ratio does not applyThis is a fund. It distributes income received from its holdings rather than paying out of its own earnings, so a payout ratio is not a meaningful measure.
  • Dividend has been cut onceAcross 5 complete years, the annual total fell in 2023. The most recent reduction was in 2023.

BBC dividend history

Annual dividend per share, 2015 to 2025.

20152017202320242025
Peak $0.6554 in 2025Year the total fellTypical payment × payments that year, split-adjusted, excluding special and one-off distributions. Robust to duplicate records in the source data. The current year is omitted while incomplete.

Recent dividend payments

The last 5 dividend payments for BBC, most recent first.
Ex-dividend datePay dateAmountType
$0.6554Annual
$0.2395Annual
$0.0823Annual
$0.3000Annual
$0.1500Annual

How much would BBC pay you?

Enter an amount and see the income this dividend would produce — per year, per payment and per month.

Calculate BBC dividend income →

BBC appears in

Frequently asked questions

Does BBC pay a dividend?
Yes. Virtus Biotech Clinical Trials ETF pays a annual dividend, currently yielding 1.25% based on trailing twelve-month payments of $0.66 per share.
How much does BBC pay in dividends?
$0.66 per share over the last twelve months, paid annual. Special and one-off distributions are excluded from that figure because they do not recur.
When is the next BBC ex-dividend date?
No upcoming ex-dividend date is currently on record for BBC. Dates appear here once the company declares them.